Logo image of UTI

UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:UTI - US9139151040 - Common Stock

22.66 USD
-0.8 (-3.41%)
Last: 11/21/2025, 8:04:10 PM
22.9374 USD
+0.28 (+1.22%)
After Hours: 11/21/2025, 8:04:10 PM
Fundamental Rating

5

Overall UTI gets a fundamental rating of 5 out of 10. We evaluated UTI against 79 industry peers in the Diversified Consumer Services industry. UTI scores excellent on profitability, but there are some minor concerns on its financial health. UTI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

UTI had positive earnings in the past year.
In the past year UTI had a positive cash flow from operations.
Of the past 5 years UTI 4 years were profitable.
Of the past 5 years UTI 4 years had a positive operating cash flow.
UTI Yearly Net Income VS EBIT VS OCF VS FCFUTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

The Return On Assets of UTI (8.52%) is better than 75.95% of its industry peers.
UTI's Return On Equity of 20.57% is amongst the best of the industry. UTI outperforms 84.81% of its industry peers.
UTI has a Return On Invested Capital of 10.86%. This is amongst the best in the industry. UTI outperforms 81.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UTI is below the industry average of 10.08%.
The 3 year average ROIC (5.11%) for UTI is below the current ROIC(10.86%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.52%
ROE 20.57%
ROIC 10.86%
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
UTI Yearly ROA, ROE, ROICUTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

The Profit Margin of UTI (7.79%) is better than 68.35% of its industry peers.
UTI's Profit Margin has improved in the last couple of years.
UTI's Operating Margin of 10.44% is fine compared to the rest of the industry. UTI outperforms 67.09% of its industry peers.
UTI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 49.65%, UTI is in line with its industry, outperforming 53.16% of the companies in the same industry.
UTI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.44%
PM (TTM) 7.79%
GM 49.65%
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
UTI Yearly Profit, Operating, Gross MarginsUTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UTI is still creating some value.
UTI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
UTI Yearly Shares OutstandingUTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
UTI Yearly Total Debt VS Total AssetsUTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.39 indicates that UTI is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.39, UTI is doing good in the industry, outperforming 79.75% of the companies in the same industry.
The Debt to FCF ratio of UTI is 0.99, which is an excellent value as it means it would take UTI, only 0.99 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.99, UTI belongs to the top of the industry, outperforming 83.54% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that UTI is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.23, UTI perfoms like the industry average, outperforming 54.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.99
Altman-Z 3.39
ROIC/WACC1.28
WACC8.51%
UTI Yearly LT Debt VS Equity VS FCFUTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

UTI has a Current Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.00, UTI perfoms like the industry average, outperforming 40.51% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that UTI should not have too much problems paying its short term obligations.
UTI's Quick ratio of 1.00 is in line compared to the rest of the industry. UTI outperforms 46.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
UTI Yearly Current Assets VS Current LiabilitesUTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

UTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.05%, which is quite impressive.
The Earnings Per Share has been growing slightly by 3.11% on average over the past years.
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.28%

3.2 Future

UTI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.86% yearly.
The Revenue is expected to grow by 8.52% on average over the next years. This is quite good.
EPS Next Y-18.25%
EPS Next 2Y-3.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.25%
Revenue Next 2Y8.52%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
UTI Yearly Revenue VS EstimatesUTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
UTI Yearly EPS VS EstimatesUTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.88, which indicates a rather expensive current valuation of UTI.
Compared to the rest of the industry, the Price/Earnings ratio of UTI indicates a somewhat cheap valuation: UTI is cheaper than 60.76% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.45, UTI is valued a bit cheaper.
UTI is valuated rather expensively with a Price/Forward Earnings ratio of 24.31.
UTI's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.46, UTI is valued a bit cheaper.
Industry RankSector Rank
PE 19.88
Fwd PE 24.31
UTI Price Earnings VS Forward Price EarningsUTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

UTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. UTI is cheaper than 65.82% of the companies in the same industry.
70.89% of the companies in the same industry are more expensive than UTI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.5
EV/EBITDA 9.71
UTI Per share dataUTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The decent profitability rating of UTI may justify a higher PE ratio.
A cheap valuation may be justified as UTI's earnings are expected to decrease with -3.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.86%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UTI!.
Industry RankSector Rank
Dividend Yield N/A

UNIVERSAL TECHNICAL INSTITUT

NYSE:UTI (11/21/2025, 8:04:10 PM)

After market: 22.9374 +0.28 (+1.22%)

22.66

-0.8 (-3.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-19 2025-11-19/amc
Earnings (Next)02-03 2026-02-03
Inst Owners94.48%
Inst Owner Change0.5%
Ins Owners2.24%
Ins Owner Change0.78%
Market Cap1.23B
Revenue(TTM)N/A
Net Income(TTM)63.10M
Analysts81.82
Price Target38.18 (68.49%)
Short Float %3.67%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.27%
Min EPS beat(2)69.26%
Max EPS beat(2)73.27%
EPS beat(4)4
Avg EPS beat(4)69.47%
Min EPS beat(4)12.21%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)80.23%
EPS beat(12)10
Avg EPS beat(12)129.78%
EPS beat(16)14
Avg EPS beat(16)215.22%
Revenue beat(2)2
Avg Revenue beat(2)2.83%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.51%
Revenue beat(4)4
Avg Revenue beat(4)2.54%
Min Revenue beat(4)1.15%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)2.98%
Revenue beat(16)15
Avg Revenue beat(16)3.43%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.02%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)1.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 19.88
Fwd PE 24.31
P/S 1.52
P/FCF 16.5
P/OCF 11.44
P/B 4.02
P/tB 4.73
EV/EBITDA 9.71
EPS(TTM)1.14
EY5.03%
EPS(NY)0.93
Fwd EY4.11%
FCF(TTM)1.37
FCFY6.06%
OCF(TTM)1.98
OCFY8.74%
SpS14.88
BVpS5.64
TBVpS4.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number12.02
Profitability
Industry RankSector Rank
ROA 8.52%
ROE 20.57%
ROCE 15.21%
ROIC 10.86%
ROICexc 13.78%
ROICexgc 15.4%
OM 10.44%
PM (TTM) 7.79%
GM 49.65%
FCFM 9.23%
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)7.97%
ROICexgc(5y)N/A
ROCE(3y)7.15%
ROCE(5y)N/A
ROICexgc growth 3Y41.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.09%
ROICexc growth 5YN/A
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.99
Debt/EBITDA 0.58
Cap/Depr 87.82%
Cap/Sales 4.08%
Interest Coverage 11.6
Cash Conversion 88.25%
Profit Quality 118.43%
Current Ratio 1
Quick Ratio 1
Altman-Z 3.39
F-Score6
WACC8.51%
ROIC/WACC1.28
Cap/Depr(3y)259.47%
Cap/Depr(5y)259.17%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-18.25%
EPS Next 2Y-3.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.28%
Revenue Next Year8.25%
Revenue Next 2Y8.52%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.69%
EBIT growth 3Y58.11%
EBIT growth 5YN/A
EBIT Next Year114.2%
EBIT Next 3Y30.39%
EBIT Next 5YN/A
FCF growth 1Y395.38%
FCF growth 3YN/A
FCF growth 5Y32.12%
OCF growth 1Y222.73%
OCF growth 3Y15.89%
OCF growth 5Y31.61%

UNIVERSAL TECHNICAL INSTITUT / UTI FAQ

What is the fundamental rating for UTI stock?

ChartMill assigns a fundamental rating of 5 / 10 to UTI.


Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?

ChartMill assigns a valuation rating of 4 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Fairly Valued.


Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?

UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.


What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?

The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 19.88 and the Price/Book (PB) ratio is 4.02.


Can you provide the expected EPS growth for UTI stock?

The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -18.25% in the next year.